adolescent | SnackSafely.com

Paliforzia (AR101)

Peanut OIT Phase 3 Trial Results Show Therapy Effective for Ages...

Dave Bloom - 2018/05/29

Aimmune plans to submit a Biologics License Application for AR101 to the FDA by the end of 2018.

dupilumab

Study: Dupilumab Showed Positive Phase 3 Results in Adolescents with Inadequately...

News Wire ~ 3rd Party Press Release - 2018/05/17

"[dupilumab] blocks the IL-4/IL-13 pathway, which is emerging as a central driver of Type 2 allergic inflammation."

Study: Adolescents with More Support Take Fewer Food Allergy Risks

Dave Bloom - 2017/01/30

Adolescents and young adults fared better with strong support from their family, friends and school.

Viaskin Peanut, Milk and Egg Patch Therapies: Promising News from the...

Dave Bloom - 2016/03/07

We are cautiously optimistic that a safe, effective, easy to administer treatment for food allergy may be on the horizon.

Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of service and Privacy Policy.

SnackSafely.com, PO Box 141, Hillsdale, NJ 07642

©2020 SnackSafely.com Inc. All rights reserved.